Serum butyrylcholinesterase and the risk of future type 2 diabetes: The Kansai Healthcare Study

Clinical Endocrinology

Volumn 80, Issue 3, 2014, Pages 362-367

  Sato, Kyoko Kogawa ^a   Hayashi, Tomoshige ^a   Maeda, Isseki ^a   Koh, Hideo ^a   Harita, Nobuko ^a   Uehara, Shinichiro ^a   Onishi, Yukiko ^a   Oue, Keiko ^b   Nakamura, Yoshiko ^b   Endo, Ginji ^a   Kambe, Hiroshi ^a,b   Fukuda, Kanji ^a,b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b West Corporation Hiroshima Health Administration Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLINESTERASE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLINESTERASE BLOOD LEVEL; CLINICAL TRIAL (TOPIC); FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; LEISURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADULT; BUTYRYLCHOLINESTERASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; HUMANS; JAPAN; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 84897099009     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12171     Document Type: Article

References (29)

1. International Diabetes Federation: IDF Diabetes Atlas Update 2012. 2012. Available at : http://www.idf.org/diabetesatlas/5e/Update2012 [accessed 13 December 2012].
2. Kutty, K.M. (1980) Biological function of cholinesterase. Clinical Biochemistry, 13, 239-243.
3. Darvesh, S., Hopkins, D.A. & Geula, C. (2003) Neurobiology of butyrylcholinesterase. Nature Reviews Neuroscience, 4, 131-138.
4. Chu, M.I., Fontaine, P., Kutty, K.M. et al. (1978) Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients. Clinica Chimica Acta, 85, 55-59.
5. Cucuianu, M., Popescu, T.A. & Haragus, S. (1968) Pseudocholinesterase in obese and hyperlipemic subjects. Clinica Chimica Acta, 22, 151-155.
6. Abbott, C.A., Mackness, M.I., Kumar, S. et al. (1993) Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clinical Science (London), 85, 77-81.
7. Nomura, F., Ohnishi, K., Koen, H. et al. (1986) Serum cholinesterase in patients with fatty liver. Journal of Clinical Gastroenterology, 8, 599-602.
8. Alcantara, V.M., Chautard-Freire-Maia, E.A., Scartezini, M. et al. (2002) Butyrylcholinesterase activity and risk factors for coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation, 62, 399-404.
9. Randell, E.W., Mathews, M.S., Zhang, H. et al. (2005) Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clinical Biochemistry, 38, 799-805.
10. Valle, A., O'Connor, D.T., Taylor, P. et al. (2006) Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clinical Chemistry, 52, 1014-1020.
11. Sato, K.K., Hayashi, T., Kambe, H. et al. (2007) Walking to work is an independent predictor of incidence of type 2 diabetes in Japanese men: the Kansai Healthcare Study. Diabetes Care, 30, 2296-2298.
12. Sato, K.K., Hayashi, T., Nakamura, Y. et al. (2008) Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care, 31, 1230-1236.
13. Kashiwagi, A., Kasuga, M., Araki, E. et al. (2012) International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation, 3, 39-40.
14. Huizenga, J.R. & Gips, C.H. (1987) Evaluation of the UV-340 spectrophotometric determination for pseudocholinesterase activity (EC 3.1.1.8) in human serum. Journal of Clinical Chemistry and Clinical Biochemistry, 25, 161-165.
15. Fossati, P. & Prencipe, L. (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry, 28, 2077-2080.
16. Kondo, A., Muranaka, Y., Ohta, I. et al. (1999) Dynamic reaction in a homogeneous HDL-cholesterol assay visualized by electron microscopy. Clinical Chemistry, 5, 1974-1980.
17. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care, 34(Suppl. 1), S62-S69.
18. Morimoto, A., Nishimura, R. & Tajima, N. (2010) Trends in the epidemiology of patients with diabetes in Japan. Japan Medical Association Journal, 53, 36-40.
19. Menard, S. (2001) Collinearity. In: S. Menard ed. Applied Logistic Regression Analysis Second Edition (Quantitative Applications in the Social Sciences). Sage Publications, Inc., California, pp.75-78.
20. Fraser, A., Harris, R., Sattar, N. et al. (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British women's heart and health study and meta-analysis. Diabetes Care, 32, 741-750.
21. Wilson, P.W., Meigs, J.B., Sullivan, L. et al. (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Archives of Internal Medicine, 167, 1068-1074.
22. Iwasaki, T., Yoneda, M., Nakajima, A. et al. (2007) Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Internal Medicine, 46, 1633-1639.
23. Hayashi, T., Boyko, E.J., McNeely, M.J. et al. (2008) Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes, 57, 1153-1155.
24. Das, U.N. (2007) Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Medical Science Monitor, 13, RA214-RA221.
25. Kamal, M.A., Tan, Y., Seale, J.P. et al. (2009) Targeting BuChEinflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease. Neurochemical Research, 34, 2163-2169.
26. Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature, 444, 860-867.
27. Hashim, Y., Shepherd, D., Wiltshire, S. et al. (2001) Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia, 44, 2227-2230.
28. Johansen, A., Nielsen, E.M., Andersen, G. et al. (2004) Largescale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia, 47, 1437-1441.
29. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus (2010) Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of Diabetes Investigation, 1, 212-228. Technology Technology